RuxolitinibRuxolitinib (sold under the brand names Jakafi and Jakavi among others, and as Opzelura in cream form) is a medication used for the treatment of intermediate or high-risk myelofibrosis, a type of myeloproliferative neoplasm that affects the bone marrow; polycythemia vera, when there has been an inadequate response to… Read from the Drugbox of the Wikipedia article Ruxolitinib, revision 1362797040.

Property

Value

Formula

C17H18N6, 306.37 g/mol

Bioavailability

95 %

Protein binding

97 %

Elimination half-life

2.9 h

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.